Erica A. Roesch - Concepedia

Author

Erica A. Roesch

Also Known As

E ROESCH, E Roesch, E. Roesch, E.A. Roesch, Erica A. Roesch, Erica Roesch

Publications

504

Citations

H-Index

Concepts

All Affiliations

Erica A. Roesch is an author at Case Western Reserve University specializing in immunology, medicine, and marrow transplantation.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	38
2	Immunology	2	2	38
3	Biomedical Engineering	1	1	22
4	Cell Biology	1	1	16
5	Cellular Therapies	1	1	22

Erica A. Roesch

Publications

148

Citations

H-Index

Page 1

	Year	Citations
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Clinical Trial Claire Wainwright, Susanna A. McColley, Paul McNally, American Journal of Respiratory and Critical Care Medicine	2023	57
Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts Abhaya Trivedi, Chase Hall, Charles W. Goss, Radiology	2022	25
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis Erica A. Roesch, Tracey L. Bonfield, Hillard M. Lazarus, Journal of Cystic Fibrosis Regenerative MedicineCell TherapyTransplantationMedicineStem Cell Transplantation	2022	22
[Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)]. A. Smolarz, Erica A. Roesch, H Lenz, PubMed	1984	16
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks Shuyu Hao, Erica A. Roesch, Aura Perez, Journal of Cystic Fibrosis InflammationTranscriptional RegulationOff-target EffectInflammatory PathwaysImmunology	2019	16
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF) Tracey L. Bonfield, Morgan T. Sutton, David Fletcher, Pharmaceuticals	2023	12

Page 1